New Jersey-based Kenvue Inc. (KVUE) is the world's largest pure-play consumer health company by revenue, backed by more than a century of trusted innovation. Home to household names such as Aveeno, BAND-AID, Johnson's, Listerine, Neutrogena, and Tylenol, the company combines science-backed products with strong healthcare professional endorsements. By delivering everyday essentials that millions rely on, Kenvue has earned a lasting place in consumers' homes and in the global consumer health market.
With a market capitalization of roughly $36.5 billion, Kenvue is gearing up to report its fiscal 2026 second-quarter results soon. Wall Street expects the consumer health giant to deliver earnings of $0.32 per share, marking a 10.3% year-over-year increase. Investors have reason for optimism, as Kenvue has surpassed analysts' earnings estimates in each of the past four quarters.